Evaluating the technical use of a Fitbit during an intervention for patients with pulmonary arterial hypertension with quality of life as primary endpoint: Lessons learned from the UPHILL study

14 June 2024

Chermaine T. Kwant, Frances S. de Man, Harm J. Bogaard, Anton Vonk Noordegraaf

https://doi.org/10.1002/pul2.12381

Abstract

This article examines technical use of Fitbit during an intervention for pulmonary hypertension (PAH)-patients. Technical issues with the device led to data being unavailable(37.5%). During intervention objective daily physical activity (DPA) decreased and subjective DPA increased. This emphasizes that an assessment of DPA in PAH requires incorporating both objective and subjective measurements.

Read the full research letter

Share:

Other materials on this topic

Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view

More from Pulmonary Circulation

Show more details

A collection of up-to-date abstracts from our premier, international, peer-reviewed, medical research journal dedicated exclusively to pulmonary circulation and pulmonary vascular disease. 

Pulmonary vascular manifestations of hereditary haemorrhagic telangiectasia
High gestational leucine level dampens WDPCP/MAPK signaling to impair the EMT and migration of cardiac microvascular endothelial cells in congenital heart defects
Pulmonary hypertension during high-dose GM-CSF therapy of autoimmune pulmonary alveolar proteinosis
Asymmetric right ventricular myocardial work correlates with gold standard measurements of cardiac function in pulmonary hypertension
Effects of dopamine β-hydroxylase inhibition in pressure overload-induced right ventricular failure
The metabolic and physiologic impairments underlying long COVID associated exercise intolerance
3-year quality of life, functional performance, and long-term survival after acute pulmonary embolism; A prospective study
Reply to the letter to the editor entitled “Bridging the species divide: The limits of rat models in capturing human PVOD mechanisms” by Perros F. et al.
Bridging the species divide: The limits of rat models in capturing human PVOD mechanisms
Infection and pulmonary vascular diseases consortium: United against a global health challenge
Delta-like ligand 4 inhibitor drug treatment induces pulmonary hypertension in cancer clinical trials
Quantitative pulmonary perfusion in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension
Comorbidity profiles and pulmonary embolism risk assessment: Leveraging the Charlson Comorbidity Index for improved prognostication in a national data set
Hemodynamic markers independent of pulmonary capillary wedge pressure can discriminate between pre and postcapillary exercise-induced pulmonary hypertension
Extracorporeal membrane oxygenation (ECMO) support for children with pulmonary hypertension: A single-institutional experience of outcomes